Wms Partners, LLC Eli Lilly & CO Transaction History

Wms Partners, LLC

$1.7 Billion
Q3 2024

A detailed history of Wms Partners, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Wms Partners, LLC holds 2,553 shares of LLY stock, worth $2.03 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

2,553

Previous 1,547 65.03%

Holding current value

$2.03 Million

Previous $1.4 Million 61.5%

% of portfolio

0.13%

Previous 0.09%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$772.14 - $960.02 $776,772 - $965,780	1,006 Added 65.03%	2,553 $2.26 Million
Q2 2024 Aug 14, 2024	SELL	$724.87 - $909.04 $12,322 - $15,453	-17 Reduced 1.09%	1,547 $1.4 Million
Q1 2024 May 15, 2024	SELL	$592.2 - $792.28 $246,947 - $330,380	-417 Reduced 21.05%	1,564 $1.22 Million
Q4 2023 Feb 12, 2024	SELL	$525.19 - $619.13 $605,018 - $713,237	-1,152 Reduced 36.77%	1,981 $1.15 Million
Q3 2023 Nov 09, 2023	SELL	$434.7 - $599.3 $57,380 - $79,107	-132 Reduced 4.04%	3,133 $1.68 Million
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $1,052 - $1,406	3 Added 0.09%	3,265 $1.53 Million
Q1 2023 May 12, 2023	SELL	$310.63 - $364.82 $22,986 - $26,996	-74 Reduced 2.22%	3,262 $1.12 Million
Q4 2022 Feb 07, 2023	SELL	$321.55 - $374.67 $36,978 - $43,087	-115 Reduced 3.33%	3,336 $1.22 Million
Q3 2022 Nov 08, 2022	BUY	$296.48 - $337.87 $16,306 - $18,582	55 Added 1.62%	3,451 $1.12 Million
Q2 2022 Aug 05, 2022	SELL	$278.73 - $327.27 $336,148 - $394,687	-1,206 Reduced 26.21%	3,396 $1.1 Million
Q1 2022 May 10, 2022	BUY	$234.69 - $291.66 $220,608 - $274,160	940 Added 25.67%	4,602 $1.32 Million
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $4,946 - $6,138	22 Added 0.6%	3,662 $1.01 Million
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $16,176 - $19,907	-73 Reduced 1.97%	3,640 $841,000
Q2 2021 Aug 13, 2021	SELL	$180.55 - $233.54 $12,638 - $16,347	-70 Reduced 1.85%	3,713 $852,000
Q4 2020 Feb 17, 2021	BUY	$130.46 - $172.63 $1,695 - $2,244	13 Added 0.34%	3,783 $639,000
Q2 2020 Aug 12, 2020	SELL	$136.42 - $164.18 $34,787 - $41,865	-255 Reduced 6.34%	3,770 $619,000
Q1 2020 May 13, 2020	SELL	$119.05 - $147.35 $22,024 - $27,259	-185 Reduced 4.39%	4,025 $558,000
Q4 2019 Feb 13, 2020	SELL	$106.92 - $132.43 $21,597 - $26,750	-202 Reduced 4.58%	4,210 $553,000
Q3 2019 Nov 07, 2019	BUY	$106.79 - $116.16 $2,883 - $3,136	27 Added 0.62%	4,412 $493,000
Q2 2019 Aug 13, 2019	SELL	$110.79 - $129.32 $138,487 - $161,650	-1,250 Reduced 22.18%	4,385 $486,000
Q1 2019 May 13, 2019	BUY	$111.31 - $131.02 $38,958 - $45,857	350 Added 6.62%	5,635 $731,000
Q4 2018 Feb 14, 2019	BUY	$105.9 - $118.64 $4,553 - $5,101	43 Added 0.82%	5,285 $612,000
Q2 2018 Aug 09, 2018	SELL	$75.7 - $86.88 $65,480 - $75,151	-865 Reduced 14.16%	5,242 $447,000
Q1 2018 May 14, 2018	SELL	$74.21 - $87.6 $5,565 - $6,570	-75 Reduced 1.21%	6,107 $472,000
Q4 2017 Feb 09, 2018	BUY	$81.94 - $87.89 $74,073 - $79,452	904 Added 17.13%	6,182 $522,000
Q3 2017 Oct 27, 2017	SELL	$77.07 - $85.54 $2,389 - $2,651	-31 Reduced 0.58%	5,278 $451,000
Q2 2017 Aug 09, 2017	BUY	N/A	5,309	5,309 $437,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wms Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wms Partners, LLC with notifications on news.

Account